Published in Curr Opin HIV AIDS on March 01, 2016
Resistance to type 1 interferons is a major determinant of HIV-1 transmission fitness. Proc Natl Acad Sci U S A (2017) 0.84
The HIV-1 transmission bottleneck. Retrovirology (2017) 0.75
Transient Peripheral Immune Activation follows Elective Sigmoidoscopy or Circumcision in a Cohort Study of MSM at Risk of HIV Infection. PLoS One (2016) 0.75
Immune activation and HIV: an enduring relationship. Curr Opin HIV AIDS (2016) 0.75
The Vaginal Microbiome and its Potential to Impact Efficacy of HIV Pre-exposure Prophylaxis for Women. Curr HIV/AIDS Rep (2017) 0.75
Vaginal lactic acid elicits an anti-inflammatory response from human cervicovaginal epithelial cells and inhibits production of pro-inflammatory mediators associated with HIV acquisition. Mucosal Immunol (2017) 0.75
Vaccine-induced immune responses against both Gag and Env improve control of simian immunodeficiency virus replication in rectally challenged rhesus macaques. PLoS Pathog (2017) 0.75
Barriers to HIV remission research in low- and middle-income countries. J Int AIDS Soc (2017) 0.75
Standard measures are inadequate to monitor pediatric adherence in a resource-limited setting. AIDS Behav (2011) 1.21
The maturing immune system: implications for development and testing HIV-1 vaccines for children and adolescents. AIDS (2006) 1.19
In-utero exposure to maternal HIV infection alters T-cell immune responses to vaccination in HIV-uninfected infants. AIDS (2014) 1.07
Distinct cytokine patterns in semen influence local HIV shedding and HIV target cell activation. J Infect Dis (2013) 0.90
Intra- and inter-clade cross-reactivity by HIV-1 Gag specific T-cells reveals exclusive and commonly targeted regions: implications for current vaccine trials. PLoS One (2011) 0.84
The oral mucosa immune environment and oral transmission of HIV/SIV. Immunol Rev (2013) 0.79
Role of semen in altering the balance between inflammation and tolerance in the female genital tract: does it contribute to HIV risk? Viral Immunol (2014) 0.78
Metabolic Syndrome After HIV Acquisition in South African Women. J Acquir Immune Defic Syndr (2016) 0.77
Genital-Systemic Chemokine Gradients and the Risk of HIV Acquisition in Women. J Acquir Immune Defic Syndr (2017) 0.75
The role of polyclonal intravenous immunoglobulin in treating HIV-infected children with severe bacterial infections: a retrospective cohort study. BMC Infect Dis (2008) 0.75
Genital - Systemic chemokine gradients and the risk of HIV acquisition in women. J Acquir Immune Defic Syndr (2016) 0.75